HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$7.24
Day range
$6.87 - $7.33
Year range
$2.86 - $11.40
Market cap
299.06M USD
Avg Volume
242.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 3.83M | 10,240.54% |
Operating expense | 16.34M | 278.31% |
Net income | -20.33M | -208.56% |
Net profit margin | -531.39 | 97.02% |
Earnings per share | -0.44 | -193.33% |
EBITDA | -18.34M | -163.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.94M | -18.37% |
Total assets | 66.31M | -3.40% |
Total liabilities | 64.80M | 1,608.38% |
Total equity | 1.51M | — |
Shares outstanding | 42.42M | — |
Price to book | 181.00 | — |
Return on assets | -62.88% | — |
Return on capital | -82.13% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -20.33M | -208.56% |
Cash from operations | -19.95M | -334.58% |
Cash from investing | — | — |
Cash from financing | -661.00K | -102.18% |
Net change in cash | -20.61M | -180.25% |
Free cash flow | -13.08M | -476.52% |
About
CEO
Founded
2013
Headquarters
Website
Employees
100